Masimo Corporation (NASDAQ:MASI) — Market Cap & Net Worth
Market Cap & Net Worth: Masimo Corporation (MASI)
Masimo Corporation (NASDAQ:MASI) has a market capitalization of $9.34 Billion ($9.34 Billion) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2342 globally and #861 in its home market, demonstrating a 0.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Masimo Corporation's stock price $179.95 by its total outstanding shares 52362808 (52.36 Million). Also see MASI current and non-current assets for a full breakdown of the balance sheet.
Masimo Corporation Market Cap History: 2015 to 2026
Masimo Corporation's market capitalization history from 2015 to 2026. Data shows growth from $2.17 Billion to $9.42 Billion (14.93% CAGR). Also see Masimo Corporation (MASI) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Masimo Corporation is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.35% | #48 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.02% | #267 of 3165 |
|
S&P Midcap 400
MID
|
$3.41 Trillion | 0.27% | #129 of 401 |
Weight: Masimo Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Masimo Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Masimo Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Masimo Corporation stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.46x
Masimo Corporation's market cap is 4.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.53 Billion | $712.90 Million | $300.67 Million | 4.95x | 11.74x |
| 2017 | $4.44 Billion | $790.25 Million | $131.62 Million | 5.62x | 33.74x |
| 2018 | $5.62 Billion | $858.29 Million | $193.54 Million | 6.55x | 29.05x |
| 2019 | $8.28 Billion | $937.84 Million | $196.22 Million | 8.83x | 42.18x |
| 2020 | $14.05 Billion | $1.14 Billion | $240.30 Million | 12.29x | 58.48x |
| 2021 | $15.33 Billion | $1.24 Billion | $229.60 Million | 12.37x | 66.77x |
| 2022 | $7.75 Billion | $2.04 Billion | $143.50 Million | 3.81x | 53.99x |
| 2023 | $6.14 Billion | $2.05 Billion | $81.50 Million | 3.00x | 75.31x |
| 2024 | $8.66 Billion | $2.09 Billion | -$304.90 Million | 4.13x | N/A |
| 2025 | $6.81 Billion | $1.53 Billion | -$151.50 Million | 4.46x | N/A |
Competitor Companies of MASI by Market Capitalization
Companies near Masimo Corporation in the global market cap rankings as of September 16, 2026. Review Masimo Corporation tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Masimo Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Masimo Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Masimo Corporation's market cap moved from $2.17 Billion to $ 9.42 Billion, with a yearly change of 14.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $9.42 Billion | +38.36% |
| 2025 | $6.81 Billion | -21.32% |
| 2024 | $8.66 Billion | +41.03% |
| 2023 | $6.14 Billion | -20.78% |
| 2022 | $7.75 Billion | -49.47% |
| 2021 | $15.33 Billion | +9.09% |
| 2020 | $14.05 Billion | +69.80% |
| 2019 | $8.28 Billion | +47.21% |
| 2018 | $5.62 Billion | +26.62% |
| 2017 | $4.44 Billion | +25.82% |
| 2016 | $3.53 Billion | +62.37% |
| 2015 | $2.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Masimo Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.34 Billion USD |
| MoneyControl | $9.34 Billion USD |
| MarketWatch | $9.34 Billion USD |
| marketcap.company | $9.34 Billion USD |
| Reuters | $9.34 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more